
ANI
Diversified biopharmaceutical company focused on rare diseases and generics.
About
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics. They are transforming into a leading Rare Disease company, with a focus on ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a strong Generics business leveraging R&D expertise and U.S.-based manufacturing.
Similar companies
Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Shares Rare Diseases, Generics
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Shares Drug Discovery, Biopharmaceutical
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Therapeutics, Rare Diseases
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Drug Discovery, Therapeutics
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Drug Discovery, Therapeutics
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Shares Drug Discovery, Rare Diseases
Key facts
- Website
- anipharmaceuticals.com
- Headquarters
- Princeton, United States
- Founded
- 1981
- Employees
- 710
- Total funding
- $11M (Seed)
- Business model
- B2B
Funding rounds
Tech stack
Detected on anipharmaceuticals.com, last scanned 29 Oct 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- Cookie consent
- Osano
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is ANI trustworthy and reputable?
StartupHub's Data Trust & Reputation score for ANI is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has ANI raised?
ANI has raised a total of $11M in funding. The most recent round on record is Seed.
How many employees does ANI have?
ANI has approximately 710 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for ANI:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

